SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-05-052385
Filing Date
2005-11-03
Accepted
2005-11-03 17:14:06
Documents
4
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a05-18107_110q.htm 10-Q 626912
2 302 CERTIFICATION a05-18107_1ex31d1.htm EX-31.1 13605
3 302 CERTIFICATION a05-18107_1ex31d2.htm EX-31.2 13891
4 906 CERTIFICATION a05-18107_1ex32d1.htm EX-32.1 7271
  Complete submission text file 0001104659-05-052385.txt   663168
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-15006 | Film No.: 051177790
SIC: 2835 In Vitro & In Vivo Diagnostic Substances